Skip to main content
Contact Us
Subscribe
E-Edition
45°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
321.66
+0.33 (+0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Smart Money Is Betting Big In AMGN Options
August 12, 2024
Via
Benzinga
MarketBeat Week in Review – 8/5 - 8/9
August 10, 2024
Stocks were looking for direction to end the week, but next week may bring more volatility with the latest reading on inflation and the start of retail earnings
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
August 09, 2024
After Monday's panicked global sell-off, markets have calmed down.
Via
Investor's Business Daily
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
August 08, 2024
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Amgen Options Trading: A Deep Dive into Market Sentiment
August 08, 2024
Via
Benzinga
Amgen's Options: A Look at What the Big Money is Thinking
August 02, 2024
Via
Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
News from a competitor gave investors an unwelcome dose of reality.
Via
The Motley Fool
Amgen's Mixed Q2 Results Highlight Obesity Drug Potential, Analysts Focus Shifts To Upcoming Clinical Readouts
August 07, 2024
Amgen posted mixed Q2 results. Analysts highlight upcoming clinical readouts in obesity and inflammatory disease as crucial. Despite some underperformance, growth prospects remain strong, with...
Via
Benzinga
Why Amgen Stock Is Down Today Despite Solid Q2 Results
August 07, 2024
Shares may have been likely to fall no matter what the company reported.
Via
The Motley Fool
Amgen Faces Near-Term Challenges But Long-Term Growth Prospects Remain Strong: Analyst
August 07, 2024
Amgen reported a 20% year-over-year increase in second-quarter sales, reaching $8.39 billion, surpassing the $8.33 billion consensus. Guidance for 2024 includes adjusted EPS of $19.10-$20.10 and...
Via
Benzinga
Amgen's MariTide Weight Loss Potential: Stock Outlook
August 07, 2024
Amgen's shares fell 2.4% after-hours trading due to a mixed earnings release. MariTide, the company's weight loss drug, is in Phase II FDA trials.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
July 30, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Amgen
July 26, 2024
Via
Benzinga
Market Whales and Their Recent Bets on AMGN Options
July 25, 2024
Via
Benzinga
Wall Street Poised For Second Day Of Gains While Bank Of Japan Makes Reassurances; Dollar Strengthens Against Yen, Crude Prices Surge: What's Driving Markets Wednesday?
August 07, 2024
The U.S.
Via
Benzinga
AMGN Stock Earnings: Amgen Misses EPS, Beats Revenue for Q2 2024
August 06, 2024
AMGN stock results show that Amgen missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Amgen Undercuts Its Buy Point On Mixed Second-Quarter Report
August 06, 2024
Amgen stock fell late Tuesday after the biotech reported lighter-than-expected second-quarter profits, though sales beat.
Via
Investor's Business Daily
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
August 07, 2024
Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to put the worst behind. Volatility continued to drop, as evidenced by...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Amgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
August 06, 2024
Via
Benzinga
Good Stocks, Strategic Options, and a 4.5% Yield: There's a Lot to Like About This Unique ETF
August 05, 2024
Covered calls can generate income from an investment portfolio but can be complex. This Amplify ETF is a simple solution.
Via
The Motley Fool
Topics
ETFs
Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday?
August 06, 2024
U.S. stock markets saw a strong recovery on Tuesday, with both the S&P 500 and the Nasdaq 100 climbing over 2%, nearly offsetting Monday’s losses. Investors took advantage of recent volatility to buy...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
So Much For Expecting The Fed To Stick The Landing
August 04, 2024
Now is not the time to be fully invested.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
3 Biotech Stocks That Could Have Investors Grinning Soon
August 02, 2024
Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.
Via
InvestorPlace
US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction
August 06, 2024
Strong sell-off may be viewed as an opportunity to load up beaten-down stocks but traders may seek evidence regarding sustainability of uptrend.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Prediction: This Could Be Amgen's Next Massive Growth Opportunity
August 02, 2024
The innovative biotech is looking for its next blockbuster.
Via
The Motley Fool
The Top 3 Biotech Stocks to Buy Now Summer 2024
July 31, 2024
These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects.
Via
InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
July 30, 2024
Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact from the 2026 Medicare drug price cuts, easing initial industry concerns.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 30, 2024
Via
Benzinga
3 Dividend-Paying ETFs to Secure Your Passive Income Stream
July 29, 2024
Passive income and ETFs represent two compelling market concepts. Why not bring the two together with dividend-paying ETFs?
Via
InvestorPlace
Topics
ETFs
3 Fabulous Growth Stocks to Buy and Hold Forever
July 24, 2024
The bull market in growth stocks is more than just chipmakers if investors will only widen their lens to see the opportunities available.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.